HIZENTRA
CSL BEHRING CANADA INC
Quick answers
Is there a shortage of HIZENTRA in Canada?
No. There is no current shortage of HIZENTRA 200MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
GAMIMUNE N 10% (IV)
TALECRIS BIOTHERAPEUTICS INC
IMMUNE GLOBULIN INTRAVENOUS (HUMAN), 5%
TALECRIS BIOTHERAPEUTICS INC
HYPERHEP B S/D
GRIFOLS THERAPEUTICS LLC
GAMASTAN S/D
GRIFOLS THERAPEUTICS LLC
HYPERTET S/D
GRIFOLS THERAPEUTICS LLC
HEPATITIS B IG INJ
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02463059
Strength
200MG
Dosage Form
Solution
Route
Subcutaneous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from CSL BEHRING CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
25% · DIN 02274663
5% · DIN 02274655
200MG · DIN 02559773
1500UNIT · DIN 02436078
500UNIT · DIN 02352575
DIN 02410826
DIN 02359251
1250UNIT · DIN 02418746
250UNIT · DIN 02418738
3000UNIT · DIN 02468077
2000UNIT · DIN 02468069
10000000000000GENOME COPIES · DIN 02542560